CD28 and neoplasm: BM-derived IMCs from non- tumor bearing mice and MDSCs from tumor-bearing mice were co-cultured with CFSE-labeled splenocytes in the presence of anti CD3/CD28 Dynabeads, and T-cell proliferation analyzed by flow cytometry after 5 days of culture.